Recombinant Proteins Combining the Inter-domain Region of Pneumococcal Surface Antigen "A" and Adaptive W-type Polypeptide of Thermotoga Bacteria as a Potential Component Base for the Development of New Diagnostics and Genetically Engineered Subunit Vaccines against Pneumococcal Infection

Article Sidebar

pdf (Русский) html (Русский) html
Published: Oct 1, 2024
DOI: https://doi.org/10.18097/BMCRM00237
Keywords:
heterologous expression; Escherichia coli; vaccine-valuable protein; thermostable protein; pneumococcal surface protein; fusion proteins

Main Article Content

O.K. Parfenova
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia
N.G. Sidorov
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia; I. Mechnikov Research Institute of Vaccines and Sera, 5А Malyi Kazennyi lane, Moscow, 105064 Russia
E.Y. Kasap
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia
R.V. Kurkin
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia
D.V. Grishin
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia

Abstract

The problems related to the development of pneumococcal vaccines require combination of traditional solutions and alternative systems optimizing this procedure. Recombinant subunit vaccines have undeniable advantages over inactivated and live-attenuated vaccines: they induce cell-mediated and humoral immunologic responses effectively and with high specificity, but without the risks associated with authentic pathogen processing. However, subunit vaccines require specific adjuvants to enhance the immune response or special fusion partners to improve solubility, expression and optimize subsequent fine purification of the protein of interest. In the framework of this work, a structurally conserved region of the most immunogenic region of the vaccine-valuable surface antigen PspA of Streptococcus pneumoniae was chosen as a model protein, and the adaptive polypeptide CheW from the hyperthermophilic microorganism Thermotoga petrophila was used as a promising fusion protein. Appropriate expression plasmid vectors were designed in silico and constructed in vitro. Efficient E. coli producer strains were obtained and appropriate conditions for heterologous production of chimeric proteins were selected. The fusion partner from T. petrophila positively influenced the properties of the resulting constructs such as thermostability, solubility, and homogeneity. During this work, the optimal pH and temperature ranges of the created proteins were determined, and the principles of low-stage purification were elaborated. We obtained and characterized new proteins, which were not previously found in nature in a similar bioconfiguration. The results indicate that the biotechnologically valuable characteristics of the fusion protein were more expressed when the adaptive CheW protein was combined with the N-terminus of the PspA antigen.

Article Details

How to Cite
Parfenova, O., Sidorov, N., Kasap, E., Kurkin, R., & Grishin, D. (2024). Recombinant Proteins Combining the Inter-domain Region of Pneumococcal Surface Antigen "A" and Adaptive W-type Polypeptide of Thermotoga Bacteria as a Potential Component Base for the Development of New Diagnostics and Genetically Engineered Subunit Vaccines against Pneumococcal Infection. Biomedical Chemistry: Research and Methods, 7(3), e00237. https://doi.org/10.18097/BMCRM00237
Issue
Vol. 7 No. 3 (2024)
Section
EXPERIMENTAL RESEARCH

References

  1. O’Brien, K.L., Wolfson, L.J., Watt, J.P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O.S., Cherian T., Hib and Pneumococcal Global Burden of Disease Study Team (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet, 374(9693), 893–902. DOI
  2. Goulart, C., Darrieux, M., Rodriguez, D., Pimenta, F.C., Brandileone, M.C., de Andrade, A.L., Leite, L.C. (2011) Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells. Vaccine, 29(8), 1634–1642. DOI
  3. Dagan, R., Melamed, R., Zamir, O., Leroy, O. (1997) Safety and imunnogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their booster ability by native polysaccharide antigens. Pediatr. Infect. Dis. J., 16(11), 1053–1059. DOI
  4. Briles, D.E., Ades, E., Paton, J.C., Sampson, J.S., Carlone, G.M., Huebner, R.C., Virolainen, A., Swiatlo, E., Hollingshead, S. (2000) Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun., 68(2), 796–800. DOI
  5. Briles, D.E., Hollingshead, S., Brooks-Walter, A., Nabors, G.S., Ferguson, L., Schilling, M., Gravenstein, S., Braun, P., King, J., Swift, A. (2000) The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine, 18(16), 1707–1711. DOI
  6. Wizemann, T.M., Heinrichs, J.H., Adamou, J.E., Erwin, A.L., Kunsch, C., Choi, G.H., Barash, S.C., Rosen, C.A., Masure, H.R., Tuomanen, E., Gayle, A., Brewah, Y.A., Walsh, W., Barren, P., Lathigra, R., Hanson, M., Langermann, S., Johnson, S., Koenig, S. (2001) Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun., 69(3), 1593–1598. DOI
  7. Converso, T.R., Goulart, C., Rodriguez, D., Darrieux, M., Leite, L.C.C. (2017) Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines. Microb. Pathog., 109, 233–238. DOI
  8. Hollingshead, S.K., Baril, L., Ferro, S., King, J., Coan, P., Briles, D.E. (2006) The Pneumococcal Proteins Epi Study Group. Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries. J. Med. Microbiol., 55(2), 215–221. DOI
  9. Daniels, C.C., Coan, P., King, J., Hale, J., Benton, K.A., Briles, D.E., Hollingshead, S.K. (2010) The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis. Infect Immun., 78(5), 2163–2172. DOI
  10. Kono, M., Hotomi, M., Hollingshead, S.K., Briles, D.E., Yamanaka, N. (2011) Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring. PLoS ONE, 6(10), e27102. DOI
  11. Roche, H., Håkansson, A., Hollingshead, S.K., Briles, D.E. (2003) Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect Immun., 71(3), 1033–1041. DOI
  12. Briles, D.E., King, J.D., Gray, M.A., McDaniel, L.S., Swiatlo, E., Benton, K.A. (1996) PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice. Vaccine, 14(9), 858–867. DOI
  13. da Costa Rodrigues, T., Zorzete, P., Miyaji, E.N., Gonçalves, V.M. (2024) Novel method for production and purification of untagged pneumococcal surface protein A from clade 1. Appl. Microbiol. Biotechnol., 108(1), 281. DOI
  14. Briles, D.E., Hollingshead, S.K., Swiatlo, E., Brooks-Walter, A., Szalai, A., Virolainen, A., McDaniel, L.S., Benton, K.A., White, P., Prellner, K., Hermansson, A., Aerts, P.C., van Dijk, H., Crain, M.J. (1997) PspA and PspC: Their potential for use as pneumococcal vaccines. Microb. Drug Resist., 3(4), 401-408. DOI
  15. Yadav, D.K., Yadav, N., Yadav, S., Haque, S., Tuteja, N. (2016) An insight into fusion technology aiding efficient recombinant protein production for functional proteomics. Arch. Biochem. Biophys., 612, 57–77. DOI
  16. Costa, S., Almeida, A., Castro, A., Domingues, L. (2014) Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: The novel Fh8 system. Front. Microbiol., 5, 63. DOI
  17. Ki, M.R., Pack, S.P. (2020) Fusion tags to enhance heterologous protein expression. Appl Microbiol. Biotechnol., 104(6), 2411–2425. DOI
  18. Grishin, D.V., Samoilenko, V.A., Gladilina, Y.A., Zhdanov, D.D., Pokrovskaya, M.V., Aleksandrova, S.S., Pokrovsky, V.S., Sokolov, N.N. (2019) Effect of heterologous expression of chemotaxis proteins from genus Thermotoga on the growth kinetics of Escherichia coli cells. Bull. Exper. Biol. Med., 167(3), 375–379. DOI
  19. Baker, M.D., Wolanin, P.M., Stock, J.B. (2006) Signal transduction in bacterial chemotaxis. Bioessays, 28(1), 9–22. DOI
  20. Randić, M., Pisanski, T. (2015) Protein alignment: Exact versus approximate. An illustration. J. Comput. Chem., 36(14), 1069–1074. DOI
  21. Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., McWilliam, H., Valentin, F., Wallace, I.M., Wilm, A., Lopez, R., Thompson, J.D., Gibson, T.J., Higgins, D.G. (2007) Clustal W and Clustal X version 2.0. Bioinformatics, 23(21), 2947–2948. DOI
  22. Drury, L. (1996) Transformation of bacteria by electroporation. Methods Mol. Biol., 58, 249–256. DOI
  23. Delaney, S., Murphy, R., Walsh, F. (2018) A comparison of methods for the extraction of plasmids capable of conferring antibiotic resistance in a human pathogen from complex broiler cecal samples. Front. Microbiol., 9, 1731. DOI
  24. Gibson, D.G. (2011) Enzymatic assembly of overlapping DNA fragments. Methods Enzymol., 498, 349–361. DOI
  25. van Rosmalen, M., Krom, M., Merkx, M. (2017) Tuning the flexibility of glycine-serine linkers to allow rational design of multidomain proteins. Biochemistry, 56(50), 6565–6574. DOI